A recent study looked at the effect of differences in macronutrient intake between dinner and breakfast on diabetes, cardiovascular health, and death from all causes. This study included adult patients with diabetes and found that when you consume fats and proteins matters. Read more
Captopril, an ACE inhibitor drug, seems to be associated with a higher rate of adverse pulmonary reactions in patients with diabetes than other ACE inhibitors or angiotensin receptor blockers (ARBs). ACE inhibitors are commonly used to treat heart and kidney conditions, which are often comorbid with diabetes. A different ACE inhibitor may be a better […]
Obstructive sleep apnea (OSA) is a common condition that causes a partial or complete block of your upper airway while sleeping. People with OSA are at higher risk of metabolic disorders like type 2 diabetes. Obesity is a common risk factor for both OSA and type 2 diabetes. Read more
Researchers have used artificial intelligence (AI) to develop an algorithm that gives people weekly guidance on managing their type 1 diabetes, based on data from a continuous glucose monitor, insulin pens, and a wearable device to monitor physical activity. The algorithm also uses a smartphone app called DailyDose. Read more
Many countries have enacted lockdowns in order to combat the spread of coronavirus (COVID-19). These stay-at-home orders have disrupted daily routines for many diabetes patients, which has created concerns over the possible consequences of added stress, isolation, and elevated blood sugars on glucose management. Read more
A new study examined randomized trials of glucose-lowering drugs, including SGLT2 inhibitors and GLP-1 agonists, and assessed drug effectiveness for four categories of patients: diabetes drug-naive or those taking metformin at low or high risk of cardiovascular disease (CVD). Read more
A new study assessed the effectiveness of nutritional ketosis, achieved through carbohydrate restriction, in the reduction of hyperglycemia in patients with type 2 diabetes. Read more
A new study has found passive stretching helps improve blood flow, making it easier for your arteries to dilate and decreasing their stiffness. These findings could have implications for diseases like diabetes and heart disease that involve impaired vascular systems. Read more
Balancing blood glucose levels during (and after) exercise with type 1 diabetes is key if you want to be successful at being physically active as an insulin user, and want to prevent hypoglycemia or hyperglycemia during exercise. Diabetes exercise expert Dr. Sheri Colberg shares some tips for managing insulin, food, and exercise. Read more
Drugs originally developed to treat Alzheimer’s Disease could be re-purposed to prevent, or possibly even reverse, the damage done to the blood vessels in people who have obesity or type 2 diabetes, researchers say. Both type 2 and obesity can contribute to stiffening of blood vessels, which increases risk for heart attack or stroke. Read […]
Previous studies have shown that people with diabetes have worse outcomes after stroke. The Stroke and Cognition (STOKOG) Collaboration study looked closely at prediabetes (impaired fasting glucose) and type 2 diabetes to determine which condition causes worse cognitive function in patients 3 to 6 months after stroke. Read more
Dexcom’s G6 Pro CGM seeks to increase use in people with prediabetes through its “blinded” mode. The G6 Pro, which consists of a sensor and transmitter unit, can store up to 10 days of glucose readings on the transmitter. These readings can then be read and analyzed retrospectively by a health care professional. Read more
A large study of Taiwanese people with type 2 diabetes examined the relationship between the intake of macronutrients, such as carbohydrates, proteins, and fats, and mortality. The researchers found dietary patterns affect men and women differently. Read on
Teplizumab may become the first antibody commercially available that can halt or delay the progression of type 1 diabetes. Researchers have found that a single 14-day infusion of teplizumab leads to a median 3-year delay in type 1 diabetes onset in high-risk individuals. Read more
The Centers for Disease Control (C.D.C.) estimates that 2% to 10% of pregnant women will develop gestational diabetes (G.D.M.), and of women with G.D.M, up to 50% will go on to develop type 2 diabetes (T2D). Current testing to predict which women are at greater risk for T2D is cumbersome, but a new test may […]
Tandem Diabetes has announced it has acquired Sugarmate, a popular app for people with diabetes who use insulin. The app allows patients to track of glucose levels and health/nutrition information, and notifies users and care providers about any fluctuation. For now, Sugarmate will continue to operate as a standalone entity and continue to provide services […]
Currently there is no such thing available as a once-weekly insulin product. However, a new type of insulin, called insulin icodec, is showing promise in testing, and may one day offer people with type 2 a more convenient option for taking insulin. Read more
Recent research into the glucagon-like peptide-1 (GLP-1) receptor agonist drug dulaglutide (Trulicity) suggest it may lower cognitive decline in type 2 diabetes, possibly in association with reduced risk of stroke associated with the drug. Read more
A new study shows that metformin, a common type 2 diabetes drug, may have a previously unknown mechanism of action, involving the release of sugars in the blood from the intestines into the stool. Better understanding of how metformin works could eventually lead to development of new and improved diabetes medications. Read more
Public Citizen, a consumer advocacy group, is urging the FDA to strengthen its warnings that SGLT-2 inhibitors are associated with increased risk of diabetic ketoacidosis, due to hundreds of cases of this potentially fatal condition in people with type 1 diabetes. SGLT-2 inhibitors are not currently approved for use in type 1 diabetes in the […]